ATARA BIOTHERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6834 USD | -4.38% |
|
-1.20% | +33.27% |
Chart calendar Atara Biotherapeutics, Inc.
e4d95223c49f.i6_u51n441SxxxAr-wi1DlELczalfgqJPKtUsbxmVvk.78e4sGiNjDnr6j1jsjiNTWFAQgeIU0ncWJgB_soVI6-m_p6RBoCyBPywUQ~c49b43356425852dd86749f46107c4bb
Upcoming events on Atara Biotherapeutics, Inc.
Past events on Atara Biotherapeutics, Inc.
| 2024-04-17 11:30 am | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 2024-03-28 08:30 am | Q4 2023 Earnings Release |
| 2024-03-06 09:10 am | TD Cowen Health Care Conference |
| 2024-01-11 12:45 pm | JPMorgan Healthcare Conference |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No: 4800 |
| 2023-11-28 10:50 am | Evercore ISI HealthCONx Conference |
| 2023-11-14 11:30 am | Stifel Healthcare Conference |
| 2023-11-01 09:00 am | Q3 2023 Earnings Call |
| 2023-11-01 08:30 am | Q3 2023 Earnings Release |
| 2023-10-10 | Cell & Gene Meeting on the Mesa Conference |
| 2023-09-07 01:50 pm | Citi BioPharma Conference |
| 2023-08-09 04:00 pm | Canaccord Genuity Growth Conference |
| 2023-08-08 04:01 pm | Q2 2023 Earnings Release |
| 2023-06-14 07:00 pm | Goldman Sachs Global Healthcare Conference |
| 2023-06-05 09:00 am | American Society of Clinical Oncology Conference - Abstract No: 7521 |
| 2023-05-31 12:00 pm | Annual General Meeting |
| 2023-05-08 04:01 pm | Q1 2023 Earnings Release |
| 2023-05-07 | Q1 2023 Earnings Call |
| 2023-03-08 02:10 pm | Cowen Health Care Conference - Panel |
| 2023-02-28 03:00 pm | H.C. Wainwright Cell Therapy Virtual Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 13,3 - | 20,3 38,9 -47.75% | 63,6 102 -37.42% | 8,57 18,1 -52.66% | 98,0 |
|
EBITDA Million USD | Released Forecast Spread | -289 -295 2.02% | -301 -302 0.5% | -331 -329 -0.71% | -275 -241 -13.94% | -271 -244 -10.98% | -51,6 |
|
EBIT Million USD | Released Forecast Spread | -296 -292 -1.39% | -309 -287 -7.6% | -340 -313 -8.92% | -281 -251 -11.8% | -276 -268 -3.01% | -85,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -291 -286 -1.86% | -307 -280 -9.47% | -340 -304 -11.96% | -228 -198 -15.5% | -276 -276 0.07% | -89,0 |
|
Net income Million USD | Released Forecast Spread | -291 -286 -1.69% | -307 -284 -8.08% | -340 -302 -12.64% | -228 -201 -13.84% | -276 -271 -1.72% | -94,6 |
|
EPS USD | Released Forecast Spread | -5,67 -5,62 -0.9% | -4,15 -3,95 -5.11% | -3,63 -3,26 -11.25% | -2,24 -1,97 -13.75% | -2,61 -2,59 -0.97% | -0,79 |
| Announcement Date | 27/02/20 | 01/03/21 | 28/02/22 | 08/02/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,55 35,1 -78.52% | 7,31 4,33 68.97% | 51,6 6,53 690.05% | 4,46 3,74 19.13% | 0,22 39,7 -99.44% | 1,23 30,7 -96% | 0,96 3,77 -74.6% | 2,14 1,27 68.37% | 4,25 14,3 -70.19% | 24,7 | 31,3 | 11,2 | 49,9 |
|
EBIT Million USD | Released Forecast Spread | -93,4 -60,4 -54.72% | -88,2 -92,1 4.2% | -32,1 -90,5 64.51% | -84,6 -78,0 -8.45% | -75,5 -43,6 -73.24% | -75,0 -40,2 -86.53% | -71,4 -68,8 -3.83% | -69,6 -69,3 -0.51% | -60,0 -51,9 -15.53% | -31,3 | -16,4 | -35,2 | 5,16 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -93,3 -56,9 -63.97% | -88,1 -96,6 8.83% | 18,5 -91,5 120.17% | -84,1 -76,5 -9.89% | -74,6 -39,0 -91.45% | -74,7 -37,3 -100.45% | -71,1 -67,7 -5.07% | -69,8 -67,8 -3% | -60,4 -61,8 2.22% | -32,2 | -15,5 | -33,3 | -8,05 |
|
Net income Million USD | Released Forecast Spread | -93,3 -55,1 -69.49% | -88,1 -95,2 7.42% | 18,5 -92,9 119.88% | -84,1 -78,4 -7.21% | -74,6 -43,4 -71.68% | -74,8 -37,3 -100.51% | -71,1 -69,4 -2.48% | -69,8 -68,6 -1.68% | -60,5 -56,6 -6.85% | -32,2 | -15,5 | -33,3 | -8,05 |
|
EPS USD | Released Forecast Spread | -0,96 -0,59 -61.35% | -0,87 -0,99 11.81% | 0,18 -0,96 118.71% | -0,82 -0,79 -3.54% | -0,72 -0,42 -70.69% | -0,72 -0,36 -101.9% | -0,68 -0,67 -2.21% | -0,66 -0,65 -0.85% | -0,56 -0,53 -6.67% | -0,25 | -0,13 | -0,25 | -0,08 |
| Announcement Date | 28/02/22 | 05/05/22 | 08/08/22 | 08/11/22 | 08/02/23 | 08/05/23 | 08/08/23 | 01/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Atara Biotherapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ATRA Stock
- Calendar Atara Biotherapeutics, Inc.
